AARDEX Group

AARDEX group will be at the Annual Meeting of the American College of Rheumatology

savethedate
OCT-2018 : AARDEX group will speak at the Annual Meeting of the American College of Rheumatology

OCT-2018 : AARDEX group will speak at the Annual Meeting of the American College of Rheumatology in Chicago.

Bernard Vrijens, CEO of AARDEX, is an invited speaker at the Annual Meeting of the American College of Rheumatology on the importance of medication adherence in digital therapeutics.

The ACR/ARHP Annual Meeting is the largest rheumatology meeting in the world and the premier educational event for physicians, healthcare professionals, and scientists who treat or research rheumatic and musculoskeletal diseases.

More on : https://www.rheumatology.org/Annual-Meeting

Share This Post

You may also like...

Breaking News

Is Neglecting Medication Adherence in Neurology Drug Trials Putting Patients at Risk?

The list of Neurological conditions is considerable, with epilepsy, Alzheimer’s disease, dementia, stroke, migraine, multiple sclerosis, Parkinson’s disease, neuro infections, and brain tumors, all attributed to this category of disease. Hundreds of millions of people worldwide are affected by neurological

Bias in clinical Research
Breaking News

Unmasking Bias in Clinical Research: A Historical Perspective

It’s an uncomfortable truth that decision-making is a murky business. While we would all like to think that our actions and the choices underpinning them are rooted in logic, integrity, and reason, the truth is not entirely clear-cut. In reality,